6533b820fe1ef96bd127923b

RESEARCH PRODUCT

Ancistrocyclinones A and B, unprecedented pentacyclic N,C-coupled naphthylisoquinoline alkaloids, from the Chinese liana Ancistrocladus tectorius

Min-juan XuYasmin HembergerEan-jeong SeoGerhard BringmannThomas EfferthRaina SeupelDoris Feineis

subject

Human leukemiaOxidative degradationStereochemistryTumor cellsOxidative phosphorylation010402 general chemistry01 natural sciencesBiochemistryAlkaloidsCell Line TumorHumansPhysical and Theoretical ChemistryCell Proliferationbiology010405 organic chemistryChemistryOrganic ChemistryAncistrocladus tectoriusIsoquinolinesbiology.organism_classificationAntineoplastic Agents PhytogenicCaryophyllalesDrug Resistance Multiple0104 chemical sciencesLianaTwo-dimensional nuclear magnetic resonance spectroscopyBerberine Alkaloids

description

Two unique pentacyclic N,C-coupled naphthylisoquinolines, the ancistrocyclinones A (5) and B (6), were discovered in the Chinese liana Ancistrocladus tectorius. Furthermore, six known, likewise N,C-coupled alkaloids, viz., ancistrocladinium A (7a) and its mono- and bisphenolic analogs 8a and 9a were isolated, along with their atropo-diastereomers 7b, 8b, and 9b. The stereostructures of 5 and 6 were determined by HRESIMS, 1D and 2D NMR, oxidative degradation, and ECD calculations. The pentacyclic ancistrocyclinones A (5) and B (6) are structurally similar to berberine alkaloids - yet arising from a most different biosynthetic pathway: they are apparently formed by N,C-coupling of their polyketide-derived molecular halves, followed by oxidative cyclo-condensation. Biomimetic conversion of the co-occurring 4'-O-demethylancistrocladinium A (8a) to ancistrocyclinone A (5) via a quinoid intermediate supported the postulated pathway. Ancistrocyclinone A (5) was found to significantly inhibit the viability of drug-sensitive human leukemia (CCRF-CEM) and multidrug-resistant tumor cells (CEM/ADR5000) with comparable efficacies.

10.1039/c7ob03092dhttp://ora.ox.ac.uk/objects/uuid: